Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05846438 · ClinicalTrials.gov registry record · NA

Effect of Drain Care on Infection Rate and Quality of Life in Implant-Based Breast Reconstruction.

A NA study of Quality of Life and Infections, sponsored by University of Missouri-Columbia.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05846438: Recruiting NA study of Quality of Life and Infections, sponsored by University of Missouri-Columbia.

NCT05846438 is a NA study of Quality of Life and Infections that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 100 participants, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05846438, a NA study of Quality of Life and Infections, is actively recruiting participants, sponsored by University of Missouri-Columbia.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn whether showering with surgical drain tubes in place after first stage breast reconstruction causes increased risk of infection. The main questions it aims to answer are: * Is there an increased risk of infection/complications with showering 48 hours after drain tubes are in place * Does showering after 48 hours with drain tubes in place affect quality of life.

Primary Outcome

The primary outcome measure will be the presence of infection as judged by the non blinded attending surgeon within the 90 day time frame during post operative evaluations. A breast infection is defined as increased erythema, warmth, and pain at the breast or systemic symptoms such as fevers and chills. Breast infections will be treated with a course of IV antibiotics and possible tissue expander removal and breast pocket irrigation and debridement in the operating room. If the attending physici

Interventions

  • OTHER Showering 48 hours after surgery

Study Locations (1)

Missouri

  • University of Missouri - Columbia

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-03-15
Est. Completion 2025-03-15
Phase NA
University of Missouri-Columbia

291 total trials

What NCT05846438 shows while recruiting

NCT05846438 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (78% lower).

The record links to 2 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which Showering 48 hours after surgery is the first listed.

NCT05846438 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT05846438 about?

NCT05846438 is a clinical study titled "Effect of Drain Care on Infection Rate and Quality of Life in Implant-Based Breast Reconstruction.". The goal of this clinical trial is to learn whether showering with surgical drain tubes in place after first stage breast reconstruction causes increased risk of infection. The main questions it aims to answer are: * Is there an increased risk of infection/complications with showering 48 hours afte...

What is the current status of trial NCT05846438?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-03-15. Estimated completion is 2025-03-15.

What conditions does trial NCT05846438 study?

This clinical trial studies the following conditions: Quality of Life, Infections.

What interventions are being tested in trial NCT05846438?

The interventions under investigation include: Showering 48 hours after surgery (OTHER).

Who is sponsoring clinical trial NCT05846438?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05846438 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05846438's enrollment target sits among peer trials

100 50th of 107 higher than 57 of 107 other Quality of Life trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05846438, the US trial registry maintained by the National Library of Medicine. NCT05846438 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.